- Nelson Advisors LLP
- About Us
- Contact Us
- Message Us
- Meet Us
- FAQ's
- Mission and Vision
- Expertise
- Services
- Lower to Mid Market
- Corporate Divestitures
- Healthcare AI
- Digital Health
- Transactions
- Behaviour Change
- App Platform Data AI
- Research
- University Business Schools
- Thought Leadership
- Careers
- Lloyd G Price
- Press and Awards
- Blog
- Insights
- Newsletter
Nelson Advisors in 2026: the boutique bank that became European HealthTech's house commentator
NA
Nelson Advisors has spent 2026 doing two things at once: closing lower-mid-market healthtech deals and telling the rest of the market what it sees. The London-based firm, co-founded by partners Lloyd Price and Paul Hemings, specialises in mergers, acquisitions, partnerships and investments for HealthTech, MedTech, Digital Health, Health IT and Health AI companies with enterprise values between roughly $25 million and $250 million.
What sets the firm apart is the volume and specificity of its public analysis. Through its Google News-approved platform healthcare.digital, a weekly newsletter with more than 5,000 subscribers, a UK HealthTech Pulse series and a growing library of deep-dive reports, Nelson Advisors publishes forecasts with numbers attached and revisits them in public. In 2026 that output has included half-year prediction updates, a 20-country "future leaders" series, strategic growth frameworks for 2027 and, due on 10th December 2026, a full European HealthTech Annual Report.
That combination of deal-side vantage point and willingness to be quoted has made the firm a regular source for trade and financial press, including Mergermarket, Healthcare Business International and Digital Health.
This article pulls together what Nelson Advisors has said about 2026, which predictions it has made for 2027, and where its views have surfaced in the press. Figures below are the firm's own or the data providers it cites, as of early November 2026.